Intracerebral grafting of cell line or patient-derived neural stem cells for the treatment of neurological disorders

Isao Date, Tetsuro Shingo, Takashi Ohmoto

Research output: Contribution to journalArticle

Abstract

Due to the development of molecular biology techniques, several types of neurotransmitter or neurotrophic factor secreting cell line can be established. These cell lines were grafted into the brain of animal models of Parkinson's disease and cerebral ischemia after encapsulating into the hollow fiber consisted of semipermeable membrane, Immunological reaction and tumor formation were prevented and functional effects were observed histologically, chemically and behaviorally. Current issues regarding encapsulated cell grafting are: delivery of neurotransmitter and neurotrophic factor simultaneously from one capsule, usage of human-derived cell lines and control of secretion from outside, There are two possible approaches regarding the usage of patient's own neural stem cells for regenerative therapy, Neural stem cells are collected from the subventricular zone of the lateral ventricle and these cells are differentiated into dopaminergic neurons using tyrosine hydroxylase induction cocktail (TH cocktail). Then, these neurons are grafted into the striatum of the patient. Another method is to inject TH cocktail into the patient's striatum in order to induce differentiation of dopaminergic neurons from the neural stem cells in vivo.

Original languageEnglish
Pages (from-to)1144-1146
Number of pages3
JournalClinical Neurology
Volume42
Issue number11
Publication statusPublished - Nov 1 2002

Fingerprint

Neural Stem Cells
Nervous System Diseases
Lateral Ventricles
Dopaminergic Neurons
Nerve Growth Factors
Tyrosine 3-Monooxygenase
Cell Line
Neurotransmitter Agents
Cell- and Tissue-Based Therapy
Brain Ischemia
Capsules
Parkinson Disease
Molecular Biology
Therapeutics
Animal Models
Neurons
Membranes
Brain
Neoplasms

Keywords

  • Cell line
  • Neural stem cell
  • Neural transplantation
  • Parkinson's disease

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Intracerebral grafting of cell line or patient-derived neural stem cells for the treatment of neurological disorders. / Date, Isao; Shingo, Tetsuro; Ohmoto, Takashi.

In: Clinical Neurology, Vol. 42, No. 11, 01.11.2002, p. 1144-1146.

Research output: Contribution to journalArticle

@article{8ddbb115f64141729fc9dbc33bb7d0fe,
title = "Intracerebral grafting of cell line or patient-derived neural stem cells for the treatment of neurological disorders",
abstract = "Due to the development of molecular biology techniques, several types of neurotransmitter or neurotrophic factor secreting cell line can be established. These cell lines were grafted into the brain of animal models of Parkinson's disease and cerebral ischemia after encapsulating into the hollow fiber consisted of semipermeable membrane, Immunological reaction and tumor formation were prevented and functional effects were observed histologically, chemically and behaviorally. Current issues regarding encapsulated cell grafting are: delivery of neurotransmitter and neurotrophic factor simultaneously from one capsule, usage of human-derived cell lines and control of secretion from outside, There are two possible approaches regarding the usage of patient's own neural stem cells for regenerative therapy, Neural stem cells are collected from the subventricular zone of the lateral ventricle and these cells are differentiated into dopaminergic neurons using tyrosine hydroxylase induction cocktail (TH cocktail). Then, these neurons are grafted into the striatum of the patient. Another method is to inject TH cocktail into the patient's striatum in order to induce differentiation of dopaminergic neurons from the neural stem cells in vivo.",
keywords = "Cell line, Neural stem cell, Neural transplantation, Parkinson's disease",
author = "Isao Date and Tetsuro Shingo and Takashi Ohmoto",
year = "2002",
month = "11",
day = "1",
language = "English",
volume = "42",
pages = "1144--1146",
journal = "Clinical Neurology",
issn = "0009-918X",
publisher = "Societas Neurologica Japonica",
number = "11",

}

TY - JOUR

T1 - Intracerebral grafting of cell line or patient-derived neural stem cells for the treatment of neurological disorders

AU - Date, Isao

AU - Shingo, Tetsuro

AU - Ohmoto, Takashi

PY - 2002/11/1

Y1 - 2002/11/1

N2 - Due to the development of molecular biology techniques, several types of neurotransmitter or neurotrophic factor secreting cell line can be established. These cell lines were grafted into the brain of animal models of Parkinson's disease and cerebral ischemia after encapsulating into the hollow fiber consisted of semipermeable membrane, Immunological reaction and tumor formation were prevented and functional effects were observed histologically, chemically and behaviorally. Current issues regarding encapsulated cell grafting are: delivery of neurotransmitter and neurotrophic factor simultaneously from one capsule, usage of human-derived cell lines and control of secretion from outside, There are two possible approaches regarding the usage of patient's own neural stem cells for regenerative therapy, Neural stem cells are collected from the subventricular zone of the lateral ventricle and these cells are differentiated into dopaminergic neurons using tyrosine hydroxylase induction cocktail (TH cocktail). Then, these neurons are grafted into the striatum of the patient. Another method is to inject TH cocktail into the patient's striatum in order to induce differentiation of dopaminergic neurons from the neural stem cells in vivo.

AB - Due to the development of molecular biology techniques, several types of neurotransmitter or neurotrophic factor secreting cell line can be established. These cell lines were grafted into the brain of animal models of Parkinson's disease and cerebral ischemia after encapsulating into the hollow fiber consisted of semipermeable membrane, Immunological reaction and tumor formation were prevented and functional effects were observed histologically, chemically and behaviorally. Current issues regarding encapsulated cell grafting are: delivery of neurotransmitter and neurotrophic factor simultaneously from one capsule, usage of human-derived cell lines and control of secretion from outside, There are two possible approaches regarding the usage of patient's own neural stem cells for regenerative therapy, Neural stem cells are collected from the subventricular zone of the lateral ventricle and these cells are differentiated into dopaminergic neurons using tyrosine hydroxylase induction cocktail (TH cocktail). Then, these neurons are grafted into the striatum of the patient. Another method is to inject TH cocktail into the patient's striatum in order to induce differentiation of dopaminergic neurons from the neural stem cells in vivo.

KW - Cell line

KW - Neural stem cell

KW - Neural transplantation

KW - Parkinson's disease

UR - http://www.scopus.com/inward/record.url?scp=0038286234&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038286234&partnerID=8YFLogxK

M3 - Article

VL - 42

SP - 1144

EP - 1146

JO - Clinical Neurology

JF - Clinical Neurology

SN - 0009-918X

IS - 11

ER -